EGF Theramed Health Corp
EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart dis… Read more
EGF Theramed Health Corp (EVAHF) - Net Assets
Latest net assets as of September 2025: $-5.98 Million USD
Based on the latest financial reports, EGF Theramed Health Corp (EVAHF) has net assets worth $-5.98 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.64K) and total liabilities ($6.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.98 Million |
| % of Total Assets | -26412.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -318.4% |
| Growth Volatility | 728.96 |
EGF Theramed Health Corp - Net Assets Trend (2012–2025)
This chart illustrates how EGF Theramed Health Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EGF Theramed Health Corp (2012–2025)
The table below shows the annual net assets of EGF Theramed Health Corp from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $-5.91 Million | -118.78% |
| 2024-06-30 | $-2.70 Million | -9.05% |
| 2023-06-30 | $-2.48 Million | -6.14% |
| 2022-06-30 | $-2.34 Million | -92.93% |
| 2021-06-30 | $-1.21 Million | +40.52% |
| 2020-06-30 | $-2.03 Million | -475.99% |
| 2019-06-30 | $541.22K | +131.94% |
| 2018-06-30 | $-1.69 Million | +50.63% |
| 2017-06-30 | $-3.43 Million | -226.76% |
| 2016-06-30 | $2.71 Million | +5.47% |
| 2015-06-30 | $2.57 Million | +138.78% |
| 2014-06-30 | $1.08 Million | +22.18% |
| 2013-06-30 | $879.96K | +1773.61% |
| 2012-06-30 | $46.97K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EGF Theramed Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5899696600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $50.64 Million | % |
| Other Comprehensive Income | $25.91K | % |
| Other Components | $3.34 Million | % |
| Total Equity | $-5.00 Million | 100.00% |
EGF Theramed Health Corp Competitors by Market Cap
The table below lists competitors of EGF Theramed Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GCI Liberty, Inc. Series C GCI Group Common Stock When Issued
NASDAQ:GLBKV
|
$348.60K |
|
HODL SPAC EUROPE AB
F:NW1
|
$348.64K |
|
Farmers Bancorp (Frankfort IN)
PINK:FABP
|
$348.77K |
|
American Helium Inc
PINK:AHELF
|
$348.82K |
|
Reco International Group Inc
V:RGI
|
$348.29K |
|
GSLR
PINK:GSLR
|
$348.05K |
|
RMB Holdings Ltd
JSE:RMH
|
$347.93K |
|
Great Ajax Corp
NYSE:AJX
|
$347.80K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EGF Theramed Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -1,340,151 to -5,000,000, a change of -3,659,849.
- Net loss of 3,000,000 reduced equity.
- Other comprehensive income increased equity by 17.
- Other factors decreased equity by 659,866.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.00 Million | -60.0% |
| Other Comprehensive Income | $17.00 | +0.0% |
| Other Changes | $-659.87K | -13.2% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares EGF Theramed Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-06-30 | $2.08 | $0.08 | x |
| 2013-06-30 | $716.58 | $0.08 | x |
| 2014-06-30 | $767.94 | $0.08 | x |
| 2015-06-30 | $32.37 | $0.08 | x |
| 2016-06-30 | $762.94 | $0.08 | x |
| 2017-06-30 | $-24.92 | $0.08 | x |
| 2018-06-30 | $-6.98 | $0.08 | x |
| 2019-06-30 | $0.71 | $0.08 | x |
| 2020-06-30 | $-3.09 | $0.08 | x |
| 2021-06-30 | $0.09 | $0.08 | x |
| 2022-06-30 | $-0.47 | $0.08 | x |
| 2023-06-30 | $-0.11 | $0.08 | x |
| 2024-06-30 | $-0.12 | $0.08 | x |
| 2025-06-30 | $-0.43 | $0.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EGF Theramed Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-270.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -6.46% | 0.00% | 0.00x | 6.39x | $-7.73K |
| 2013 | -38.64% | 0.00% | 0.00x | 1.30x | $-428.00K |
| 2014 | -5.07% | 0.00% | 0.00x | 1.93x | $-161.97K |
| 2015 | -10.83% | 0.00% | 0.00x | 1.40x | $-534.71K |
| 2016 | -7.20% | 0.00% | 0.00x | 1.90x | $-465.77K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-36.59 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-766.56K |
| 2019 | -2659.76% | 0.00% | 0.00x | 5.28x | $-14.45 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-20.18 Million |
| 2021 | -1064.75% | 0.00% | 0.00x | 13.09x | $-983.15K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.25 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-508.71K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-135.24K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.50 Million |
Industry Comparison
This section compares EGF Theramed Health Corp's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EGF Theramed Health Corp (EVAHF) | $-5.98 Million | -6.46% | N/A | $348.50K |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |